Zacks Investment Research has upgraded Danaher Corporation (NYSE:DHR) to Hold in a statement released 8/31/2016.
Advertisement
According to Zacks, “Danaher has an impressive earnings history, beating estimates thrice and meeting once in the trailing four quarters”. PEG perhaps more useful shows that Danaher Corp. has a value for PEG of 27.57. They issued a market perform rating for the company. (NYSE:DHR) is trading at, 81.2 (0.84% today), Danaher Corp. has a dividend yield of 0.79%, and this is covered by a payout ratio of 11.60%. During its last trading session, Stock traded with the total exchanged volume of 3.62 million shares.
U.S. based company, Danaher Corp.’s (DHR)’s latest closing price distance was 11.78% from the average-price of 200 days while it maintained a distance from the 50 Day Moving Average at 1.74% and 0.39% compared with the 20 Day Moving Average.
Danaher Corp. (NYSE:DHR) last announced its quarterly earnings data on Monday, July 25th. On the other hand, in the March 2016 quarter the company recorded a net $5.39B revenue with earnings per share of $0.79. During the same period in the prior year, the company posted $1.08 earnings per share. The company had revenue of $5785.00 million for the quarter, compared to analysts expectations of $5766.84 million. The corporation has an earnings per share (EPS) ratio of 3.93.
A number of FactSet analysts shared their views about the current stock momentum. Goldman Sachs Group Inc. started coverage on Danaher Corp.in a research note on Tuesday, July 5th. Analyst had a consensus of $1.22. The rating firm gave a Neutral rating to this stock in a research note on Jul 5, 2016.Bernstein analysts issued their verdict on Danaher Corporation (NYSE:DHR) recently.
Shares of Danaher Corp. Argus reiterated a “buy” rating and issued a $90.00 price target (down from $110.00) on shares of Danaher Corp.in a research report on Thursday, July 28th. Morgan Stanley now has a $86.00 target price on the stock.
In other Danaher Corp. news, insider Thomas Patrick Joyce, Jr. sold 45,897 shares of Danaher Corp. stock in a transaction on Monday, August 1st.
The Company has 684.76 million shares outstanding and 606.06 million shares were floated in market. Also, CFO Daniel L. Comas sold 96,446 shares of Danaher Corp. stock in a transaction on Wednesday, July 27th. The share price is now at 18.61% for the past six months. The company traded as low as $81.26 on the day. The disclosure for this sale can be found here. Significant increases in trading volume and price appreciation together could signal heavy volume accumulation by institutional investors.
Green Valley Investors added new position in Danaher Corporation during the most recent quarter end. Washington Trust Bank now owns 1,950 shares of the company’s stock valued at $197,000 after buying an additional 915 shares during the last quarter. Carnick & Kubik LLC acquired a new stake in shares of Danaher Corp. during the first quarter valued at approximately $171,000.
Advertisement
Danaher Corporation (Danaher) designs manufactures and markets professional medical industrial and commercial products and services. The Company operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental, and Industrial Technologies. The Test & Measurement segment offers test measurement and monitoring products.
